News

NCS Multistage Reports Strong Third Quarter 2024 Financials

NCS Multistage Reports Strong Third Quarter 2024 Financials

NCS Multistage Holdings Inc. Reports Third Quarter Results

Third Quarter Results Summary

  • Total revenues reached $44 million, reflecting a 15% increase year-over-year, partly thanks to higher international revenues.
  • Net income for the quarter stood at $4.1 million with diluted earnings of $1.60 per share, compared to $4.4 million and $1.77 per share from last year.
  • Adjusted EBITDA increased to $7.1 million, up $0.3 million from last year.
  • The first nine months of 2024 generated cash flows from operations of $2.1 million and free cash flow less distributions was $0.4 million, marking a $3.3 million improvement over the same period in 2023.
  • The company held $15.3 million in cash and $8.6 million in total debt as of September 30, 2024.

NCS Multistage Holdings, Inc. (NASDAQ: NCSM), a key player in oil and natural gas well construction and completions, presented a commendable financial performance for the quarter ending September 30, 2024. Their operations reflect a strategic focus on enhancing international services which have contributed significantly to the revenue growth.

Financial Highlights for Q3

During the third quarter of 2024, NCS Multistage's total revenues saw a remarkable increase, hitting $44.0 million compared to $38.3 million from the same period last year. This surge was driven primarily by growth across international services and product sales, particularly in U.S. and Canadian markets. However, lower service revenues within the U.S. and modulated international sales did mitigate some of the revenue gains.

Key Revenue Drivers

The substantial increase in international revenues was notably attributed to successful tracer operations in the Middle East and sales of frac systems in the North Sea. In the U.S., the surge in revenues also showcased the effectiveness of joint ventures, specifically with Repeat Precision, LLC, which recorded higher perfuming gun sales.

Proving their resilience, the company managed to report a quarter-on-quarter revenue growth of 48%, despite facing some seasonal declines. The recovery of Canadian operations following previous adverse weather conditions also enhanced overall performance.

Profit Margins and Expense Management

Gross profit for the third quarter was reported at $17.8 million, achieving a gross margin of 41%, compared to $15.2 million with a 40% margin in Q3 2023. The improvement in gross margins is a testament to increased higher-margin international projects and sales in the United States. Adjusted gross profit reached $18.5 million, reflecting an adjusted gross margin of 42%.

Administrative and Operating Expenses

Operating expenses, specifically selling, general, and administrative (SG&A) expenses increased to $14.1 million in Q3 2024, largely due to heightened incentive accruals. However, these were somewhat offset by cost-saving initiatives implemented via company restructuring.

Operational Improvements and Outlook

NCS Multistage's operational strategies continue to pay dividends, showcasing their ability to maximize output amid volatile market conditions. CEO Ryan Hummer stated, "Our results underscore the commitment to innovation and market adaptability that our team embodies." The first nine months of 2024 marked a 10% increase in revenue compared to the previous year, highlighting effective management and execution on core strategies.

The company demonstrated significant operational leverage, improving free cash flow and producing robust cash management strategies, thus continuing to solidify their financial footing in the O&G industry.

Looking Ahead

For the remainder of 2024, NCS expects continued revenue enhancement across U.S., Canadian, and international markets. Nonetheless, they forecast a modest sequential revenue decline of 5-15%, anticipating market fluctuations and potential winter operational challenges.

Frequently Asked Questions

What were the total revenues for NCS Multistage in Q3 2024?

The total revenues reached $44 million, indicating a 15% increase year-over-year.

How did NCS Multistage's net income in Q3 2024 compare to last year?

Net income for the quarter was $4.1 million, compared to $4.4 million in Q3 2023.

What is NCS Multistage's approach to managing operating expenses?

NCS Multistage has focused on implementing cost-saving strategies through restructuring efforts to manage SG&A expenses.

Which areas contributed most to NCS's revenue growth in Q3 2024?

Growth was primarily driven by increases in international services and stronger U.S. product sales.

What is the company's outlook for Q4 2024?

NCS Multistage anticipates continued revenue performance improvements but projects a sequential reduction in revenues of about 5-15% due to market efficiencies and seasonal challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 9

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 136

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 347

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 118

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 53

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Infosys: Leading Innovation and Growth in IT Services

Updated Category News Views 139

Infosys: Fastest Growing IT Services Brand Infosys, a standout leader in the realm of digital services, has recently been hailed as the fastest-growing IT services brand. Their extraordinary annual growth rate of 15% in brand value is a testament to their robust market strategies and trusted services. Recognition by Brand Finance The prestigious brand valuation firm Brand...

Continue Reading
Sanofi's Sarclisa Gains FDA Approval for First-Line Myeloma Care

Updated Category News Views 63

Sarclisa Gains FDA Approval: A New Hope Recently, Sarclisa, developed by Sanofi’s SA (NASDAQ: SNY), received pivotal FDA approval as a first-line treatment for adult patients with newly diagnosed multiple myeloma (NDMM) who are unable to undergo autologous stem cell transplantation (ASCT). This approval represents a significant breakthrough for those grappling with this...

Continue Reading
Rayonier Clarifies the Tax Implications of 2024 Dividends

Updated Category News Views 320

Understanding Rayonier's 2024 Dividend Tax Treatment Rayonier Inc. (NYSE: RYN), a prominent timberland real estate investment trust, has recently announced the tax implications associated with its 2024 dividend distributions on common stock. As a shareholder, grasping the tax treatment of these dividends is essential for effective financial planning. Dividend Overview and...

Continue Reading
Delta Airlines Eyes Strong Year-End Recovery Amid Challenges

Updated Category News Views 153

Delta Airlines Expects a Resilient Year-End Performance Delta Airlines Inc (NYSE: DAL) is navigating a challenging landscape yet remains optimistic about closing the year on a positive note. Following a significant technology failure this summer that impacted operations, the airline is poised to leverage the holiday travel surge to bolster its earnings. Impact of...

Continue Reading
Cyngn Secures $33 Million Funding to Propel Growth Strategy

Updated Category News Views 146

Cyngn Aims for Growth with New Funding Cyngn enters the new year with enthusiasm and significant momentum, fueled by its recent funding of $33 million aimed at enhancing production and deployment of its autonomous industrial vehicles. The focus is particularly on the DriveMod Tuggers and the highly anticipated DriveMod Forklifts, showcasing the company's commitment to...

Continue Reading